Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,92118,940 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Development of an ultra-high dose rate rotational linac for FLASH Radiotherapy
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

Abstract Radiotherapy is used to treat 60% of the cancer patients and 40% of curative cases. However, normal tissue toxicities still prevent radiotherapy from achieving more effect...

$7.47M
USD
Completed NON-SBIR/STTR RPGS
Development of B-cell-based vaccine for Glioblastoma
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Immunotherapy has revolutionized the treatment of many tumors. However, most GBM patients have not, so far, benefited from immunotherapeutic treatment. Wit...

$3.66M
USD
Completed NON-SBIR/STTR RPGS
Development of an ultra-high dose rate rotational linac for FLASH Radiotherapy
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2022

Abstract Radiotherapy is used to treat 60% of the cancer patients and 40% of curative cases. However, normal tissue toxicities still prevent radiotherapy from achieving more effect...

$5.82M
USD
Completed NON-SBIR/STTR RPGS
Development of B-cell-based vaccine for Glioblastoma
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Immunotherapy has revolutionized the treatment of many tumors. However, most GBM patients have not, so far, benefited from immunotherapeutic treatment. Wit...

$3.48M
USD
Active NON-SBIR/STTR RPGS
Optimizing Tobacco Treatment Delivery for People Living with HIV
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2027

With advances in antiretroviral therapy (ART), people living with HIV (PLWH) are living longer, are more likely to die from non-AIDS-related causes, and are less likely to die from...

$484.5K
USD
Completed NON-SBIR/STTR RPGS
Development of an ultra-high dose rate rotational linac for FLASH Radiotherapy
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

Abstract Radiotherapy is used to treat 60% of the cancer patients and 40% of curative cases. However, normal tissue toxicities still prevent radiotherapy from achieving more effect...

$6.65M
USD
Completed NON-SBIR/STTR RPGS
Optimizing Tobacco Treatment Delivery for People Living with HIV
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

With advances in antiretroviral therapy (ART), people living with HIV (PLWH) are living longer, are more likely to die from non-AIDS-related causes, and are less likely to die from...

$197.5K
USD
Completed TRAINING, INDIVIDUAL
Investigating sliding clamps and their contribution to genome stability
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2021 – 2024

Project Summary All cells must replicate their genome once per cell cycle.To ensure proper duplication, cells integrate hundreds of factors that copy, surveil, and repair our genet...

$310.3K
USD
Completed TRAINING, INDIVIDUAL
Investigating sliding clamps and their contribution to genome stability
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2021 – 2024

Project Summary All cells must replicate their genome once per cell cycle. To ensure proper duplication, cells integrate hundreds of factors that copy, surveil, and repair our gene...

$317.5K
USD
Completed TRAINING, INDIVIDUAL
Investigating sliding clamps and their contribution to genome stability
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2021 – 2023

Project Summary All cells must replicate their genome once per cell cycle. To ensure proper duplication, cells integrate hundreds of factors that copy, surveil, and repair our gene...

$74.2K
USD
Completed NON-SBIR/STTR RPGS
Elucidating the role of the noncoding genome in neuroblastoma
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2021 – 2026

Project Summary Neuroblastoma (NB) remains one of the deadliest childhood cancers.NB exhibits a paucity of recurrent protein coding mutations and few targetable mutations (2-5), pr...

$4.03M
USD
Completed RESEARCH CENTERS
P30 Administrative Supplement to Cancer Center Support Grant to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network.
NATIONAL CANCER INSTITUTE Dartmouth College United States 2021 – 2023

Abstract: Please see the Research plan, as the FOA specified to put the abstract in this section.

$1.15M
USD
Completed NON-SBIR/STTR RPGS
Elucidating the role of the noncoding genome in neuroblastoma
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2021 – 2026

Project Summary Neuroblastoma (NB) remains one of the deadliest childhood cancers. NB exhibits a paucity of recurrent protein coding mutations and few targetable mutations (2-5), p...

$3.95M
USD
Completed NON-SBIR/STTR RPGS
Elucidating the role of the noncoding genome in neuroblastoma
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2021 – 2026

Project Summary Neuroblastoma (NB) remains one of the deadliest childhood cancers. NB exhibits a paucity of recurrent protein coding mutations and few targetable mutations (2-5), p...

$4.46M
USD
Completed NON-SBIR/STTR RPGS
Elucidating the role of the noncoding genome in neuroblastoma
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2021 – 2026

Project Summary Neuroblastoma (NB) remains one of the deadliest childhood cancers. NB exhibits a paucity of recurrent protein coding mutations and few targetable mutations (2-5), p...

$3.28M
USD
Completed NON-SBIR/STTR RPGS
Preventing Myeloma Relapse after Autologous Stem Cell Transplantation with Decoy Resistant IL-18
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Research Center United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT Multiple myeloma is the second most common hematological malignancy and despite improved patient outcomes in the era of novel agents, it remains largely in...

$1.66M
USD
Completed SBIR-STTR RPGS
Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine
NATIONAL CANCER INSTITUTE Immune Modulatory Therapies, Llc United States 2021 – 2022

Abstract Phosphatidylserine (PS) is emerging as an attractive immunotherapeutic target in the light of mounting evidence highlighting its causal link to immune suppression.We have...

$2.93M
USD
Completed TRAINING, INDIVIDUAL
Implementing Photodissociation Mass Spectrometry to study Disease and Lipid Structure
NATIONAL CANCER INSTITUTE University of Texas At Austin United States 2021 – 2024

Abstract Lipids fulfill an array of cellular functions by composing cellular membranes, engaging in signaling pathways, and modulating protein structure.Disruptions in carefully re...

$366.3K
USD
Completed TRAINING, INDIVIDUAL
Implementing Photodissociation Mass Spectrometry to study Disease and Lipid Structure
NATIONAL CANCER INSTITUTE University of Texas At Austin United States 2021 – 2022

Abstract Lipids fulfill an array of cellular functions by composing cellular membranes, engaging in signaling pathways, and modulating protein structure. Disruptions in carefully r...

$121.6K
USD
Completed TRAINING, INDIVIDUAL
Investigating the Role of Cdc73 in T-cell Acute Lymphoblastic Leukemia (T-ALL)
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2024

PROJECT SUMMARY About 60% of T-cell acute lymphoblastic leukemia (T-ALL) patients have activating NOTCH1 mutations, making NOTCH1 the most prevalent oncogene in this cancer. In ear...

$389.6K
USD